News – Page 2 – San Diego Biotechnology Network

Mirati Therapeutics Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of MRTX849, A Novel KRAS G12C Inhibitor

January 15, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, announced today that it has dosed the first patient in a Phase 1/2 clinical trial of MRTX849, an investigational KRAS G12C… […]

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results

January 15, 2019 sandiegobiotech Comments Off

Conference Call and Webcast Scheduled for Tuesday, February 5

SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2018 financial results after the Nasdaq… […]

Large Study Identifies Genetic Variants Linked to Risk Tolerance and Risky Behaviors

January 14, 2019 sandiegobiotech Comments Off

An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in … […]

GenScript Launches Novel Technology Licensed from Amgen for Accelerating Protein and Antibody Purification

January 14, 2019 sandiegobiotech Comments Off

AmMag SA magnetic purification system first to offer high throughput of large samples, accelerating early stage drug development

SAN DIEGO, Jan. 14, 2019 /PRNewswire/ — GenScript®, the world’s leading gene synthesis provider, announced today at PepT… […]

DNA startup Roswell gets $32M for gene sequencing nanotech – The San Diego Union-Tribune

January 12, 2019 Mary Canady 0

Roswell Biotechnologies, a life-science upstart in San Diego, has secured $32 million from investors to develop an unusual new way to sequence DNA for cheap — a feat they hope will dramatically bring down the […]

GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology

January 10, 2019 sandiegobiotech Comments Off

Dr. Stone will lead GigaGen’s immuno-oncology research and discovery of first-in-class monoclonal antibody therapies

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2019 /PRNewswire/ — GigaGen Inc., a biopharmaceutical company developing novel antibody therap… […]

Halozyme Provides 2019 Pipeline Update And Financial Guidance At 37th Annual JP Morgan Healthcare Conference

January 9, 2019 sandiegobiotech Comments Off

– Anticipated ENHANZE® Partner Progress in 2019 Includes One FDA Approval, New Regulatory Submissions and a New Phase 3 Initiation- Completed Enrollment in Phase 3 Metastatic Pancreas Cancer Study with Data Projected in Second Half of 2019

SAN DIEGO,… […]

Fire Station at UC San Diego Approved by San Diego City Council

January 8, 2019 sandiegobiotech Comments Off

The University of California San Diego will soon be home to a fire station, after the San Diego City Council approved construction of the much-needed facility during its Jan. 8 meeting.
[…]

In Promise of True Liquid Biopsy for Cancer, Chip Company BioFluidica® Awarded $1.7 Million by National Cancer Institute/National Institutes of Health for Clinical Trial in Children with Acute Lymphoblastic Leukemia

January 7, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 7, 2019 /PRNewswire/ — BioFluidica, a privately held cancer diagnostics company, has been awarded an SBIR Phase II National Institutes of Health grant of $1.7 million for a clinical trial in support of “Increased sensitivity of mini… […]

Ansun Biopharma To Present at Biotech Showcase(TM) 2019 In San Francisco

January 7, 2019 sandiegobiotech Comments Off

SAN DIEGO, Jan. 7, 2019 /PRNewswire/ — Ansun Biopharma, Inc., today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the most important week in healthcare at the Hilton San Francisco Union Square.

Ansun… […]